SCHEMBL23635832

SCHEMBL23635832

CCOC(=O)c1sc2cccc(F)c2c1COc1ccc(C(N)=O)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
STING1 Q86WV6 8/20 0.55
ALDH1A1 P00352 4/20 0.53
KDM4E B2RXH2 3/20 0.53
HPGD P15428 2/20 0.53
GLA P06280 1/20 0.53
GAA P10253 1/20 0.53
TSHR P16473 1/20 0.53
HSD17B10 Q99714 1/20 0.53
MAPK1 P28482 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
RXFP1 Q9HBX9 1/20 0.46
THRB P10828 1/20 0.46
LMNA P02545 2/20 0.44
PARP10 Q53GL7 3/20 0.40
PARP15 Q460N3 2/20 0.40
MAPT P10636 2/20 0.39
HTT P42858 1/20 0.39
PARP14 Q460N5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23635831 0.91 ALDH1A1 (0.55) STING1ALDH1A1KDM4EHPGDGLA
SCHEMBL23635887 0.89 STING1 (0.62) STING1ALDH1A1KDM4EHPGDGLA
SCHEMBL30697680 0.89 STING1 (0.62) STING1ALDH1A1KDM4EHPGDGLA
SCHEMBL23630792 0.88 STING1 (0.67) STING1PARP10PARP15
SCHEMBL23635882 0.88 ALDH1A1 (0.52) STING1ALDH1A1KDM4EHPGDGLA
SCHEMBL30313238 0.85 ALDH1A1 (0.59) STING1ALDH1A1KDM4EHPGDGLA
SCHEMBL23635796 0.85 ALDH1A1 (0.59) STING1ALDH1A1KDM4EHPGDGLA
SCHEMBL26778192 0.84 STING1 (0.49) STING1ALDH1A1KDM4EHPGDGLA
SCHEMBL23111980 0.84 STING1 (0.65) STING1ALDH1A1KDM4EHPGDGLA
SCHEMBL23630820 0.83 STING1 (0.59) STING1ALDH1A1KDM4EHPGDGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793988-B1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-11-15 EP disclosed
EP-3793988-B1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-11-15 EP disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20210214333-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD. (AU) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 STING1 1/4885ALDH1A1 4660/4885KDM4E 1469/4885
US-20210214333-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 STING1 1/4885ALDH1A1 4719/4885KDM4E 1519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.